Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis

Figure 4

Increased circulating IGF-I does not alter growth in ErbB2-induced mammary gland turmors. Graphs plotting individual tumor growth curves for ErbB2 (left) and bigenic (right) females. Statistical analysis revealed that increased circulating levels of IGF-I (right) had no significant (p = 0.23) affect on mammary tumor growth compared to ErbB2 only induced mammary tumors. N = 16 for ErbB2 group and 15 for TTR-IGF-I-ErbB2 bigenic group.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us